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Synthesis of compound 2
Reaction of adduct 1 and 3-bromopropyl amine hydrobromide to yield 4-(3-bromopropyl) 10oxa-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione was also adapted from literature. 3 Compound 2 was purified by column chromatography using Ethyl acetate:Hexane (1:1, v/v) eluent. Yield: 51 %. S4 Figure S2 . 13 C NMR spectra of compound 2 in CDCl 3 .
Synthesis of monomer 3a
Compound 2 (0.5 g, 1.75 mmol) and excess amount of trimethylphosphine solution in THF (Molarity =1 mol L -1 ) (5.25 mL, 5.25 mmol) was mixed in a glass vial and 5 mL THF was added to the mixture. The reaction vessel was covered with aluminium foil. The reaction was performed under nitrogen at 50C and stirred for 24h. The product was precipitated and washed with THF. It was dried under nitrogen and stored in desiccator. Yield 80 %. 
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Synthesis of monomer 3b
Compound 2 (0.5 g, 1.75 mmol) and excess amount of triethylphosphine solution in THF (M=1 mol L -1 ) (5.25 mL, 5.25 mmol) was mixed in a glass vial and 5 mL THF was added to the mixture.
The reaction vessel was covered with aluminium foil. The reaction was performed under nitrogen at 50C and stirred for 24 h. Precipitation of the product in reaction vessel was observed and THF was added for further precipitation. The product was washed with THF. It was dried under nitrogen and stored in desiccator. Yield 90 %. 
Synthesis of monomer 3c
Compound 2 (0.5 g, 1.75 mmol) was dissolved in 8 mL THF in a glass vial and excess amount of tripropylphosphine solution in THF (d: 0,801 g mol -1 , 97 %) (1.119 mL, 0.896 mmol) was added with syringe under nitrogen. The reaction was performed at 50C and stirred for 24 h.
Precipitation was observed and the reaction vial was cooled in ice bath for further precipitation. The product was washed with diethyl ether-THF (1:1 v/v) mixture. It was dried under nitrogen and stored in desiccator. Yield 77 %.
S8 Figure S7 . 1 H and 31 P NMR spectra of monomer 3c in DMSO-d 6 . Figure S8 . 13 C NMR spectra of monomer 3c in DMSO-d 6 .
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Synthesis of monomer 3d
Compound 2 (1 g, 3.5 mmol) was dissolved in 12 mL THF in a glass vial and excess amount of t-butylphosphine solution in THF (d: 0.834 g mol -1 ) (3 mL) was added with syringe under nitrogen. The reaction was performed at 50C and stirred for 24 h. Precipitation was observed and the reaction vial was cooled in ice bath for further precipitation. The product was washed with diethyl ether. It was dried under nitrogen and stored in desiccator. Yield 11 %. 
Synthesis of monomer 3e
Compound 2 (0.5 g, 1.75 mmol) and excess amount of triphenylphosphine (1.376 g, 5.25 mmol) was mixed in 11 mL ethyl acetate. The reaction was performed under nitrogen in a sealed vessel at 50C and stirred for 24 h. Precipitation of the quaternary phosphonium product in reaction vessel was observed. It was washed with ethyl acetate and THF. It was dried under nitrogen and stored in desiccator. Yield 11 %. S11 Figure S11. 1 H and 31 P NMR spectra of monomer 3e in CDCl 3 .
Figure S12
. 13 C NMR spectra of monomer 3e in CDCl 3 .
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Synthesis of monomer 3f
Compound 2 (0.5 g, 1.75 mmol) and excess amount of Tris(4-methoxyphenyl)phosphine 
Determination of Solution Phase Antibacterial Activity
The MIC of the cationic polymers were determined by a standard serial dilution technique with an inoculum of 5 x 10 5 cell mL -1 in Müller Hinton and Middle Brook Broth medium for bacteria and Sabouroud Dextrose Broth medium for fungi. Three bacteria and one fungi strains were used: Escherichia coli (ATCC 10536), Staphylococcus aureus (ATCC 6538), Mycobacterium tuberculosis (ATCC 27294) and Candida albicans (ATCC 10231). Polymer solutions were prepared by dissolution in water (4a, 4b, 4c and 4d_3k) or DMSO (4d_10k, 4e
and 4f) and further diluted with buffer. The concentration of the polymers ranged from 512 µg mL -1 to 4 µg mL -1 . The MIC of the polymers was determined after 12 h of incubation at 37C by optical density (OD) measurements. The MIC was defined as the lowest concentration at which bacterial growth was inhibited.
Determination of Hemolytic Activity
Blood sample was taken from healthy adult volunteer using vacuum tubes with sodium heparin (15 IU mL -1 ). Oral consent was obtained following a brief discussion that outlined the 
DLS Assay
Stock solution of water soluble polymers (4a_3k, 4a_10k, 4b_3k, 4b_10k) were prepared in phosphate-buffered saline (PBS) (pH:7) at a concentration of 1 mg mL -1 .
Stock solution of water insoluble polymers (4e_3k, 4e_10k, 4f_3k, 4f_10k) were prepared in dimethyl sulfoxide (DMSO) at a concentration of 1 mg mL -1 . 100 µL of these stock solutions were added to 900 µL of PBS giving a final concentration of 0,1 mg/mL and zeta potentials were measured. For the assays with bacteria; one active (4e_3k) and one inactive (4b_3k) polymers were used. Bacteria solution (10 9 cell mL -1 ) and 100 µL DMSO/ 900 µL Bacteria solution mixture were used as two different blanks, 100 µL of stock solutions (1 mg mL -1 ) were diluted with 100 µL PBS to give a concentration of 0,5 mg mL -1 . Finally, 100 µL of this solution (0,5 mg mL -1 ) was added to 900 µL of bacteria solution and zeta potentials were measured.
Before measuring zeta potential, all polymer, bacteria and polymer-bacteria solutions were filtered through 45-µL filters. 
